Bleckmann A - Search Results

1

High Expression of NT5DC2 Is a Negative Prognostic Marker in Pulmonary Adenocarcinoma.

Schulze AB, Kuntze A, Schmidt LH, Mohr M, Marra A, Hillejan L, Schulz C, Görlich D, Hartmann W, Bleckmann A, Evers G. Schulze AB, et al. Among authors: bleckmann a. Cancers (Basel). 2022 Mar 9;14(6):1395. doi: 10.3390/cancers14061395. Cancers (Basel). 2022. PMID: 35326547 Free PMC article.

2

To treat or not to treat: A rare case of response to pembrolizumab-based immunotherapy-chemotherapy in non-small cell lung cancer with acute liver failure due to multiple bile duct metastases.

Shaforostova I, Huss S, Gerwing M, Evers G, Bleckmann A. Shaforostova I, et al. Among authors: bleckmann a. Thorac Cancer. 2021 Feb;12(4):553-556. doi: 10.1111/1759-7714.13793. Epub 2020 Dec 27. Thorac Cancer. 2021. PMID: 33369224 Free PMC article.

3

Long-Term Follow-Up on Systemic Bevacizumab Treatment in Recurrent Respiratory Papillomatosis.

Evers G, Schliemann C, Beule A, Schmidt LH, Schulze AB, Kessler C, Hoffmann TK, Wiewrodt R, Groll AH, Bleckmann A, Rudack C, Berdel WE, Mohr M. Evers G, et al. Among authors: bleckmann a. Laryngoscope. 2021 Jun;131(6):E1926-E1933. doi: 10.1002/lary.29351. Epub 2020 Dec 31. Laryngoscope. 2021. PMID: 33382105

4

Immune Checkpoint Inhibitor-Associated Myocarditis: A Run of Bad Luck or Rather Deficient-Monitoring Protocol?

Chatzantonis G, Evers G, Meier C, Bietenbeck M, Florian A, Klingel K, Bleckmann A, Yilmaz A. Chatzantonis G, et al. Among authors: bleckmann a. JACC Case Rep. 2020 Apr 15;2(4):630-635. doi: 10.1016/j.jaccas.2019.12.047. eCollection 2020 Apr. JACC Case Rep. 2020. PMID: 34317309 Free PMC article.

5

Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.

Kemper M, Evers G, Schulze AB, Sperveslage J, Schülke C, Lenz G, Herold T, Hartmann W, Schildhaus HU, Bleckmann A. Kemper M, et al. Among authors: bleckmann a. Oncotarget. 2021 Sep 14;12(19):1946-1952. doi: 10.18632/oncotarget.28062. eCollection 2021 Sep 14. Oncotarget. 2021. PMID: 34548910 Free PMC article.

6

Real-world multicentre analysis of neoadjuvant immunotherapy and chemotherapy in localized or oligometastatic non-small cell lung cancer (KOMPASSneoOP).

Faehling M, Witte H, Sebastian M, Ulmer M, Sätzler R, Steinestel K, Brückl WM, Evers G, Büschenfelde CMZ, Bleckmann A. Faehling M, et al. Among authors: bleckmann a. Ther Adv Med Oncol. 2022 Mar 25;14:17588359221085333. doi: 10.1177/17588359221085333. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35356258 Free PMC article.

7

High-Throughput Profiling of Colorectal Cancer Liver Metastases Reveals Intra- and Inter-Patient Heterogeneity in the EGFR and WNT Pathways Associated with Clinical Outcome.

Menck K, Wlochowitz D, Wachter A, Conradi LC, Wolff A, Scheel AH, Korf U, Wiemann S, Schildhaus HU, Bohnenberger H, Wingender E, Pukrop T, Homayounfar K, Beißbarth T, Bleckmann A. Menck K, et al. Among authors: bleckmann a. Cancers (Basel). 2022 Apr 21;14(9):2084. doi: 10.3390/cancers14092084. Cancers (Basel). 2022. PMID: 35565214 Free PMC article.

8

Addendum: Polyclonal on- and off-target resistance mutations in an EML4-ALK positive non-small cell lung cancer patient under ALK inhibition.

Kemper M, Evers G, Schulze AB, Sperveslage J, Schülke C, Lenz G, Herold T, Hartmann W, Schildhaus HU, Bleckmann A. Kemper M, et al. Among authors: bleckmann a. Oncotarget. 2022 Nov 2;13:1216. doi: 10.18632/oncotarget.28293. Oncotarget. 2022. PMID: 36342457 Free PMC article. No abstract available.

9

PD-L1 on large extracellular vesicles is a predictive biomarker for therapy response in tissue PD-L1-low and -negative patients with non-small cell lung cancer.

Schöne N, Kemper M, Menck K, Evers G, Krekeler C, Schulze AB, Lenz G, Wardelmann E, Binder C, Bleckmann A. Schöne N, et al. Among authors: bleckmann a. J Extracell Vesicles. 2024 Mar;13(3):e12418. doi: 10.1002/jev2.12418. J Extracell Vesicles. 2024. PMID: 38453684 Free PMC article.

10

Effects of the Novel PFKFB3 Inhibitor KAN0438757 on Colorectal Cancer Cells and Its Systemic Toxicity Evaluation In Vivo.

De Oliveira T, Goldhardt T, Edelmann M, Rogge T, Rauch K, Kyuchukov ND, Menck K, Bleckmann A, Kalucka J, Khan S, Gaedcke J, Haubrock M, Beissbarth T, Bohnenberger H, Planque M, Fendt SM, Ackermann L, Ghadimi M, Conradi LC. De Oliveira T, et al. Among authors: bleckmann a. Cancers (Basel). 2021 Feb 28;13(5):1011. doi: 10.3390/cancers13051011. Cancers (Basel). 2021. PMID: 33671096 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

152 results

Search Page